PMID- 31789588 OWN - NLM STAT- MEDLINE DCOM- 20200207 LR - 20200207 IS - 1473-5644 (Electronic) IS - 0022-2615 (Linking) VI - 69 IP - 1 DP - 2020 Jan TI - Methicillin-resistant Staphylococcus epidermidis isolates with reduced vancomycin susceptibility from bloodstream infections in a neonatal intensive care unit. PG - 41-45 LID - 10.1099/jmm.0.001117 [doi] AB - Introduction. Vancomycin has become the first-line therapy for most infections caused by methicillin-resistant staphylococci.Aim. To evaluate the vancomycin MIC, staphylococcal cassette chromosome mec (SCCmec) types and clonality of coagulase-negative staphylococci (CoNS) isolates recovered from neonates with true primary bloodstream infections (BSI).Methodology. CoNS isolates were prospectively recovered from blood cultures of non-repetitive patients admitted to a neonatal intensive care unit (NICU) in a tertiary-care hospital during a 3-year period. BSI was defined based on established criteria. Micro-organisms were identified phenotypically and by PCR. MIC-values for vancomycin and oxacillin were determined by broth dilution method and E-test. The SCCmec type conferring methicillin resistance was determined by multiplex PCR. The heterogeneous vancomycin (hV) resistance phenotype was screened on brain heart infusion agar containing 4 microg ml(-1) of vancomycin. The clonality was investigated by PFGE.Results. Seventy-four CoNS isolates were recovered from blood cultures of neonates during the study period but only 40 (54 %) were associated with true primary BSI. Nine (22.5%) babies died. Staphylococcus epidermidis was the most prevalent species (95 %; 38/40). All S. epidermidis isolates were methicillin-resistant (MR). SCCmec type IV was predominant (55.3 %; 21/38). Most (80.0 %; 32/38) isolates exhibited vancomycin MIC-values of 2-4 microg ml(-1) not associated with the SCCmec type or clonality. Sixteen (42.1%) isolates displayed hV resistance. All babies who died were harbouring MR-S. epidermidis exhibiting vancomycin MICs of 2-4 microg ml(-1).Conclusion. The findings of this study demonstrated that blood invasive MR-S. epidermidis isolates recovered at NICU tend to show decreased vancomycin susceptibility making therapy of those fragile patients difficult. FAU - Peixoto, Patricia Borges AU - Peixoto PB AD - Instituto de Ciencias Biologicas e Naturais, Universidade Federal do Triangulo Mineiro, Uberaba, Minas Gerais, Brazil. FAU - Massinhani, Fernando Henrique AU - Massinhani FH AD - Instituto de Ciencias Biologicas e Naturais, Universidade Federal do Triangulo Mineiro, Uberaba, Minas Gerais, Brazil. FAU - Netto Dos Santos, Katia Regina AU - Netto Dos Santos KR AD - Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. FAU - Chamon, Raiane Cardoso AU - Chamon RC AD - Departamento de Patologia, Faculdade de Medicina, Universidade Federal Fluminense, Niteroi, Rio de Janeiro, Brazil. AD - Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. FAU - Silva, Renata Beatriz AU - Silva RB AD - Instituto de Ciencias Biologicas e Naturais, Universidade Federal do Triangulo Mineiro, Uberaba, Minas Gerais, Brazil. FAU - Lopes Correa, Fabio Ederson AU - Lopes Correa FE AD - Instituto de Ciencias Biologicas e Naturais, Universidade Federal do Triangulo Mineiro, Uberaba, Minas Gerais, Brazil. FAU - Barata Oliveira, Cristina da Cunha Hueb AU - Barata Oliveira CDCH AD - Instituto de Ciencias da Saude, Universidade Federal do Triangulo Mineiro, Uberaba, Minas Gerais, Brazil. FAU - Oliveira, Adriana Goncalves AU - Oliveira AG AD - Instituto de Ciencias Biologicas e Naturais, Universidade Federal do Triangulo Mineiro, Uberaba, Minas Gerais, Brazil. LA - eng PT - Journal Article PL - England TA - J Med Microbiol JT - Journal of medical microbiology JID - 0224131 RN - 0 (Anti-Bacterial Agents) RN - 6Q205EH1VU (Vancomycin) RN - Q91FH1328A (Methicillin) SB - IM MH - Anti-Bacterial Agents/pharmacology MH - Bacteremia/drug therapy MH - Disease Susceptibility MH - Drug Resistance, Bacterial/genetics MH - Humans MH - Infant MH - Infant, Newborn MH - Intensive Care Units, Neonatal MH - Intensive Care, Neonatal MH - Methicillin/*pharmacology MH - Methicillin Resistance/*genetics MH - Methicillin-Resistant Staphylococcus aureus/drug effects MH - Microbial Sensitivity Tests MH - Sepsis/drug therapy MH - Staphylococcal Infections/drug therapy MH - Staphylococcus/drug effects/isolation & purification MH - Staphylococcus epidermidis/*drug effects/isolation & purification/metabolism MH - Vancomycin/pharmacology MH - Vancomycin Resistance/genetics OTO - NOTNLM OT - SCCmec OT - coagulase-negative staphylococci OT - neonate OT - sepsis OT - vancomycin heteroresistance EDAT- 2019/12/04 06:00 MHDA- 2020/02/08 06:00 CRDT- 2019/12/03 06:00 PHST- 2019/12/04 06:00 [pubmed] PHST- 2020/02/08 06:00 [medline] PHST- 2019/12/03 06:00 [entrez] AID - 10.1099/jmm.0.001117 [doi] PST - ppublish SO - J Med Microbiol. 2020 Jan;69(1):41-45. doi: 10.1099/jmm.0.001117.